Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch - Trial NCT06048536
Access comprehensive clinical trial information for NCT06048536 through Pure Global AI's free database. This Phase 2 trial is sponsored by Viatris Inc. and is currently Recruiting. The study focuses on Contraception. Target enrollment is 168 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Viatris Inc.
Timeline & Enrollment
Phase 2
Mar 07, 2023
Dec 31, 2023
Primary Outcome
Proportion of responder overall (subjects with no ovulation in both treatment cycles),Proportion of responder in cycle (subjects with no ovulation in one of the treatment cycles)
Summary
A single-center, randomized, open-label, parallel-group, multi-arm, phase II clinical trial
 in healthy women aged 18 to 35 years who have a documented ovulatory cycle prior to
 randomization.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06048536
Non-Device Trial